Clinicians should: Assess baseline HbA1c and current glycemic control before discontinuation Implement or intensify alternative therapies (metformin, SGLT2 inhibitors, or other agents) before or concurrent with tirzepatide cessation Increase home glucose monitoring frequency for several weeks post-discontinuation Schedule follow-up to evaluate metabolic stability Special consideration for insulin or sulfonylurea users : Patients taking these medications alongside tirzepatide may need proactive dose adjustments when stopping tirzepatide to prevent hypoglycemia
The median age of overweight or obese patients was 47 years and 72% were female
By week 40, most participants had achieved 80% or more of their total weight loss
If you are researching regulatory notes, payment options, and regional availability, the overview at spinbet-aus.com can be a helpful starting point that points you toward official resources, documented terms, and current promotional structures, enabling more confident decisions and ensuring your time is spent assessing verified information rather than guesswork or hearsay
If youd like to understand the broader scope of what our clinic offers, read about medical weight loss options at Avellina Aesthetics on our blog
Both Retatrutide and Tirzepatide produce favorable body composition outcomes when combined with appropriate nutrition and exercise